Advertisement
DERM vs INDV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DERM is a Buy and INDV is a Buy.
DERM's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for DERM turned positive on October 29, 2026. Looking at past instances where DERM's MACD turned positive, the stock continued to rise in 50 of 53 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where DERM's RSI Oscillator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
Following a +9.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where DERM advanced for three days, in 232 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
DERM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 61 cases where DERM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 80%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on DERM as a result. In 83 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The 10-day moving average for DERM crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The 50-day moving average for DERM moved below the 200-day moving average on October 23, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DERM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for DERM entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.210) is normal, around the industry mean (8.029). P/E Ratio (-21.773) is within average values for comparable stocks, (-0.853). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (2.865) is also within normal values, averaging (178.797).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. DERM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DERM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
INDV in upward trend: price rose above 50-day moving average on October 29, 2026
INDV moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend. In 17 of 21 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 81%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INDV's RSI Oscillator exited the oversold zone, 22 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 38 of 62 cases where INDV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 61%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on INDV as a result. In 67 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for INDV just turned positive on October 26, 2026. Looking at past instances where INDV's MACD turned positive, the stock continued to rise in 35 of 47 cases over the following month. The odds of a continued upward trend are 74%.
Following a +2.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where INDV advanced for three days, in 138 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
INDV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for INDV moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INDV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
The Aroon Indicator for INDV entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-20.687) is normal, around the industry mean (8.029). P/E Ratio (12.597) is within average values for comparable stocks, (-0.853). Projected Growth (PEG Ratio) (0.060) is also within normal values, averaging (2.152). Dividend Yield (0.052) settles around the average of (0.047) among similar stocks. P/S Ratio (3.330) is also within normal values, averaging (178.797).
The Tickeron Profit vs. Risk Rating rating for this company is 39 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. INDV’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 64 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
DERM | INDV | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 60 | 40 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 14 Undervalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 39 | |
SMR RATING 1..100 | 96 | 64 | |
PRICE GROWTH RATING 1..100 | 77 | 57 | |
P/E GROWTH RATING 1..100 | 16 | 93 | |
SEASONALITY SCORE 1..100 | 45 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INDV's Valuation (5) in the null industry is in the same range as DERM (14) in the Biotechnology industry. This means that INDV’s stock grew similarly to DERM’s over the last 12 months.
INDV's Profit vs Risk Rating (39) in the null industry is somewhat better than the same rating for DERM (100) in the Biotechnology industry. This means that INDV’s stock grew somewhat faster than DERM’s over the last 12 months.
INDV's SMR Rating (64) in the null industry is in the same range as DERM (96) in the Biotechnology industry. This means that INDV’s stock grew similarly to DERM’s over the last 12 months.
INDV's Price Growth Rating (57) in the null industry is in the same range as DERM (77) in the Biotechnology industry. This means that INDV’s stock grew similarly to DERM’s over the last 12 months.
DERM's P/E Growth Rating (16) in the Biotechnology industry is significantly better than the same rating for INDV (93) in the null industry. This means that DERM’s stock grew significantly faster than INDV’s over the last 12 months.
| DERM | INDV | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 89% | 1 day ago 69% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 84% | 1 day ago 74% |
| MACD ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 82% | 1 day ago 72% |
| Advances ODDS (%) | 5 days ago 85% | 1 day ago 67% |
| Declines ODDS (%) | 1 day ago 84% | 18 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 88% | 1 day ago 76% |
| Aroon ODDS (%) | 1 day ago 83% | 1 day ago 68% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DERM’s FA Score shows that 2 FA rating(s) are green while INDV’s FA Score has 1 green FA rating(s).
- DERM’s FA Score: 2 green, 3 red.
- INDV’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DERM’s TA Score shows that 4 TA indicator(s) are bullish while INDV’s TA Score has 7 bullish TA indicator(s).
- DERM’s TA Score: 4 bullish, 6 bearish.
- INDV’s TA Score: 7 bullish, 3 bearish.
Price Growth
DERM (@Pharmaceuticals: Generic) experienced а -3.62% price change this week, while INDV (@Pharmaceuticals: Generic) price change was +4.98% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.90%. For the same industry, the average monthly price growth was -8.35%, and the average quarterly price growth was -0.07%.
Reported Earning Dates
DERM is expected to report earnings on Nov 11, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-0.90% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
Advertisement
DERM and
Correlation & Price change
A.I.dvisor indicates that over the last year, DERM has been loosely correlated with APUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DERM jumps, then APUS could also see price increases.
| Ticker / NAME | Correlation To DERM | 1D Price Change % | ||
|---|---|---|---|---|
| DERM | 100% | -7.35% | ||
| APUS - DERM | 49% Loosely correlated | -3.99% | ||
| CHRS - DERM | 27% Poorly correlated | -9.72% | ||
| INDV - DERM | 24% Poorly correlated | +2.57% | ||
| CRDL - DERM | 23% Poorly correlated | -6.31% | ||
| ETON - DERM | 23% Poorly correlated | -2.63% | ||
More | ||||
INDV and
Correlation & Price change
A.I.dvisor indicates that over the last year, INDV has been loosely correlated with SUPN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INDV jumps, then SUPN could also see price increases.
| Ticker / NAME | Correlation To INDV | 1D Price Change % | ||
|---|---|---|---|---|
| INDV | 100% | +2.57% | ||
| SUPN - INDV | 42% Loosely correlated | N/A | ||
| EBS - INDV | 31% Poorly correlated | -5.43% | ||
| AMRX - INDV | 29% Poorly correlated | -4.97% | ||
| ELAN - INDV | 27% Poorly correlated | +4.51% | ||
| XERS - INDV | 27% Poorly correlated | -5.04% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XCLR | 28.27 | N/A | N/A |
| Global X S&P 500 Collar 95-110 ETF (XCLR) | |||
| GUSA | 65.18 | N/A | N/A |
| Goldman Sachs MarketBeta U.S. 1000 Equity ETF (GUSA) | |||
| DSEP | 48.59 | -0.15 | -0.31% |
| FT Vest U.S. Equity Deep Buffer ETF - September (DSEP) | |||
| RMMZ | 13.83 | -0.05 | -0.36% |
| RiverNorth Managed Duration Municipal Income Fund II | |||
| TPFG | 23.29 | -0.19 | -0.79% |
| Timothy Plan Free Cash Flow Growth ETF (TPFG) | |||